Suppr超能文献

机器人辅助根治性肾输尿管切除术:治疗上尿路尿路上皮癌的一种安全有效的选择,尤其适用于新手外科医生。

Robot-Assisted Radical Nephroureterectomy: A Safe and Effective Option for Upper Tract Urothelial Carcinoma, Especially for Novice Surgeons.

作者信息

Chang Chia-Lun, Tsai Chung-You, Cheng Pai-Yu, Wu Wen-Jeng, Tsai Yao-Chou

机构信息

Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei 231405, Taiwan.

School of Medicine, Buddhist Tzu Chi University, Hualien 97004, Taiwan.

出版信息

Cancers (Basel). 2025 Apr 22;17(9):1394. doi: 10.3390/cancers17091394.

Abstract

BACKGROUND

Radical nephroureterectomy (RNU) is the standard treatment for upper tract urothelial carcinoma (UTUC). Minimally invasive techniques like robotic (RARNU) and laparoscopic (LRNU) RNU offer potential benefits over open surgery, but their comparative oncologic outcomes are debated.

METHODS

This retrospective, multicenter study analyzed 2037 Taiwanese patients undergoing RNU between 2010 and 2022. Missing data was addressed using multiple imputations. Overlap weighting was applied to balance patient characteristics between the RARNU and LRNU groups. Survival outcomes were compared using Kaplan-Meier analysis and Cox regression.

RESULTS

After excluding the missing data, 405 patients underwent RARNU, and 1262 underwent LRNU. After adjusting for baseline differences, both groups showed comparable rates of surgical complications, residual tumor, UTUC-related mortality, and disease recurrence. The median follow-up was similar (52.4 vs. 51.6 months, = 0.91). Using Kaplan-Meier survival curve analysis, overall survival, cancer-specific survival, and disease-free survival were similar between the two groups.

CONCLUSIONS

This study shows that RARNU for UTUC has comparable oncological and perioperative outcomes to pure LRNU. RARNU may be easier for surgeons to adopt, particularly those with limited laparoscopic experience.

摘要

背景

根治性肾输尿管切除术(RNU)是上尿路尿路上皮癌(UTUC)的标准治疗方法。机器人辅助根治性肾输尿管切除术(RARNU)和腹腔镜根治性肾输尿管切除术(LRNU)等微创技术与开放手术相比具有潜在优势,但其肿瘤学疗效的比较仍存在争议。

方法

这项回顾性多中心研究分析了2010年至2022年间接受RNU的2037例台湾患者。使用多重填补法处理缺失数据。应用重叠加权法平衡RARNU组和LRNU组之间的患者特征。使用Kaplan-Meier分析和Cox回归比较生存结果。

结果

排除缺失数据后,405例患者接受了RARNU,1262例患者接受了LRNU。在调整基线差异后,两组的手术并发症、残留肿瘤、UTUC相关死亡率和疾病复发率相当。中位随访时间相似(52.4个月对51.6个月,P = 0.91)。使用Kaplan-Meier生存曲线分析,两组的总生存、癌症特异性生存和无病生存相似。

结论

本研究表明,UTUC的RARNU与单纯LRNU的肿瘤学和围手术期疗效相当。RARNU可能更容易被外科医生采用,尤其是那些腹腔镜经验有限的医生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267c/12071112/2098dcf13415/cancers-17-01394-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验